Recruiting Melanoma Studies in Chandler
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
The study is for patients with advanced melanoma who are eligible for standard therapy with Pembrolizumab....
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called cemiplimab (also known as REGN2810), called "study drugs". The study i...
About Melanoma Clinical Trials in Chandler
Melanoma is the most serious type of skin cancer, developing from the pigment-producing cells known as melanocytes. While less common than other skin cancers, melanoma is more likely to spread. Immunotherapy and targeted therapy have revolutionized melanoma treatment.
There are currently 2 melanoma clinical trials recruiting participants in Chandler, ARIZONA. These studies are seeking a combined 1,300 participants. Research is being sponsored by Eikon Therapeutics, Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Melanoma Clinical Trials in Chandler — FAQ
Are there melanoma clinical trials in Chandler?
Yes, there are 2 melanoma clinical trials currently recruiting in Chandler, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chandler?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chandler research site will contact you about next steps.
Are clinical trials in Chandler free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chandler studies also compensate for your time and travel.
What melanoma treatments are being tested?
The 2 active trials in Chandler are testing new therapies including novel drugs, biologics, and treatment approaches for melanoma.
Data updated March 2, 2026 from ClinicalTrials.gov